杂志简称：biotechnol adv
中文译名：《生物技术进展》
收录属性：高质量科技期刊（t1）, scie（2024版）, 目次收录（知网）,英文期刊,
自引率：1.50%
投稿方向：工程技术、biotechnology & applied microbiology生物工程与应用微生物
SCI/E期刊基本信息
出版周期：年8期 地区：英国
中科院分区：1区
是否TOP：TOP期刊
是否综述：综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 0734-9750；EISSN 1873-1899
杂志语言：英语
出版国家：英国
杂志官网 联系方式
出版地址：THE BOULEVARD,LANGFORD LANE,KIDLINGTON,OXFORD,ENGLAND,OX5 1GB
杂志邮箱：
投稿网址：https://www.editorialmanager.com/jba
杂志官方网址：https://www.journals.elsevier.com/biotechnology-advances
出版商网址：http://www.elsevier.com
杂志投稿要求
投稿须知【杂志社官方网站信息】
Guide for Authors
Biotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues. Authoritative articles on current developments and future trends in biotechnology are empathized. Submissions of appropriate manuscripts are invited. A wide audience of scientists, engineers and others is addressed: students, instructors, researchers, practitioners, managers, governments and related stakeholders. Special issues are published on selections of presentations at recent relevant conferences as arranged with the organizations. Special issues are also produced to review areas of biotechnology which are inadequately covered in a focused and/or timely manner in regular issues, as arranged with invited guest editors.
Types of paper
Review articles, both short and longer extensive ones are considered. The review article should demonstrate insights of the topic with regard to current developments and future trends in biotechnology. The author(s) should give evidence in the literature of appropriate expertise, for example in the publications cited in the proposed manuscript.
Contact details for submission
Papers should be submitted using the Biotechnology Advances online submission system, https://www.editorialmanager.com/jba For questions, please visit our Support Center
Plagiarism
All JBA submissions will be subjected to plagiarism evaluation using the software of iThenticate/Crosscheck prior to editorial processing. Authors should be experienced enough to differentiate ethical behaviors (e.g. citation and quotation) from unethical ones (e.g. general plagiarism, self-plagiarism, and copy-and-paste). Manuscripts that cannot pass the plagiarism evaluation pre-screening will be automatically rejected without review and the plagiarism evaluation will not be provided to authors. For more information, please go to: https://www.elsevier.com/editors/perk/plagiarism-detection
Ethics in publishing
Please see our information on Ethics in publishing.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within five years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.